2028년까지 중동 및 아프리카 면역조직화학 시장 예측 – 애플리케이션(진단 및 약물 테스트), 제품(항체, 장비, 시약 및 키트) 및 최종 사용자(병원 및 진단 실험실, 연구소, 다른 사람)

TIPRE00025749 | Pages: 150 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

시장 소개

아랍에미리트(UAE), 사우디아라비아, 남아프리카공화국은 MEA의 3대 주요 국가입니다. 사우디아라비아는 2021년 이 지역에서 가장 큰 면역조직화학 시장이었습니다. 사우디아라비아는 중동 및 아프리카에서 가장 빠르게 성장하는 국가 중 하나이며, 암으로 고통받는 인구가 많아 성장을 촉진하고 있습니다. 또한 사우디아라비아(KSA)는 새로운 비전염성 질병(NCD) 치료 모델의 예방과 홍보에 우선순위를 두는 사우디 비전 2030을 가지고 있습니다. 또한, 한국표준협회에서는 2030년까지 암 발생률과 유병률 추정치가 2배로 증가할 것으로 예상하고 있습니다. WHO 2018에 따르면 국내에서 약 24,485건의 새로운 암 사례가 등록되었습니다. 그 중 유방암 환자는 약 3,629명이었다. 대장암 환자는 3,564명이었다. 진단 절차를 제공하는 실험실의 존재도 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 사우디아라비아에 본사를 둔 Al Borg Medical Laboratories는 광범위한 일반, 전문, 하위 전문 실험실 테스트를 제공합니다. 중동 전역에 우수하고 최첨단 진단검사의학 서비스를 제공합니다. 사우디 식품의약청(Saudi Food and Drug Authority) 전략 계획(2018~2022)은 최근 정부가 제3차 연간 전략 계획으로 제안한 것입니다. 이 프로젝트에는 의약품, 식품, 의료기기 규제 당국이 개발한 비전과 전략적 우선순위가 통합되어 있습니다. 그들은 또한 연구 목적으로 리야드에 중앙 테스트 연구소를 설립할 계획입니다. 또한 정부는 엔터테인먼트, 건강, 스포츠 및 교육을 장려하기 위한 계획에 2020년까지 약 133억 달러(500억 리얄)를 지출할 계획입니다. 따라서 보건 및 교육을 위한 더 나은 시설의 증가는 면역조직화학 시장에 좋은 기회를 창출할 가능성이 높습니다.

COVID-19의 경우 MEA는 특히 남아프리카공화국에서 큰 영향을 받습니다. 경제적 불확실성과 계속되는 갈등이 이 지역의 상황을 더욱 악화시키고 있습니다. 예를 들어, 시리아, 리비아, 예멘과 같은 국가는 폭력적인 분쟁을 겪고 있으며 강력한 공중 보건 조치를 시행할 수 없습니다. 이란은 미국의 제재로 심각한 경제 불황에 빠졌다. 또한 중동 국가의 경제 안정의 주요 원천은 석유 생산과 수출이다. 그러나 최근의 전염병은 중동 경제에 혼란을 야기하고 있습니다. 제품, 특히 원유에 대한 국내 및 외부 수요의 급격한 감소와 노동력 부족으로 인한 생산 중단은 이 지역에서 관찰되는 주요 영향입니다.  이 지역의 코로나바이러스 확산은 의료 전문가들에게 큰 부담을 안겨주었습니다. 심장외과 의사들은 응급 심장수술, 코로나바이러스 환자 관리, 바이러스 확산 방지를 위한 안전수칙 이행으로 과부하를 겪었다. 선택 수술에 영향을 미치는 바이러스로의 급속한 확산. 이러한 요인들은 MEA 면역조직화학 시장의 성장을 방해할 것으로 예상됩니다.

시장 개요 및 역학

MEA 면역조직화학 시장은 2021년 8,898만 달러에서 2028년 1억 3,650만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 6.3%로 성장할 것으로 예상됩니다. 최근 몇 년 동안 생명공학 산업은 엄청나게 빠른 속도로 발전하고 있습니다. 제조업체는 최신 의약품, 디지털화 진행, 치료 방식, 지속적인 관리 변화를 통해 다양한 의료 문제에 직면하고 있습니다. 세계보건기구(WHO) 통계에 따르면 인구는 매년 1.2%씩 증가하고 있으며, 이는 노년층 인구의 증가로 이어진다. WHO는 또한 65~80세 인구의 비율이 2000년 22%에서 2030년 28%로 증가할 것이라고 밝혔습니다. 또한, 도시화 증가와 중산층 인구 증가로 인해 제약회사는 합리적인 의약품을 제조하게 되었습니다. 시장의 성장을 주도하는 역할을 담당합니다. 이들 제제는 환자 안전을 위한 엄격한 규제 지침을 거쳐 시장에서 생산된다. 연구 & 혁신적인 제품을 탐색, 검토 및 생산하는 방법, 선불 결제 및 마일스톤, 제품을 향상시키는 방법, 출시 전 제품 효율성 및 규정 준수를 보여주는 방법과 비교한 개발 비용입니다. 따라서 투자자, 생물약제학, 생명공학 산업의 높은 연구 투자는 예측 기간 동안 면역조직화학 시장의 성장을 촉진할 것으로 예상됩니다. R&D 활동에 대한 투자 증가는 향후 업계 성장의 기반을 마련했습니다. 많은 과학자들은 다른 과학자들과 협력하여 생물반응기를 위한 다양한 제품을 제공합니다. 이러한 요인들은 생명공학 및 바이오제약 산업을 증가시켜 MEA 시장의 성장을 주도할 것으로 예상되는 효율적인 테스트를 달성할 것으로 예상됩니다.

주요 시장 부문

제품 측면에서 항체 부문은 2020년 MEA 면역조직화학 시장에서 가장 큰 점유율을 차지했습니다. 적용 측면에서 진단 부문은 2020년 MEA 면역조직화학 시장에서 더 큰 시장 점유율을 차지했습니다. , 병원 및 진단 실험실 부문은 2020년 최종 사용자를 기준으로 MEA 면역조직화학 시장에서 더 큰 점유율을 차지했습니다.  

주요 출처 및 회사 목록

MEA 면역조직화학 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Abcam plc입니다. 애질런트 테크놀로지스, Inc.; 바이오SB; BIO-RAD LABORATORIES INC.; 다나허; F. HOFFMANN-LA ROCHE LTD.; 머크 KGaA; 퍼킨엘머 주식회사; 및 THERMO FISHER SCIENTIFIC INC.

구매 이유 보고서

< ul>
  • MEA 면역조직화학 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별
  • MEA 면역조직화학 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
  • 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 MEA 면역조직화학 시장에서 M&A 및 파트너십 거래를 효율적으로 계획합니다.
  • 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. 다양한 세그먼트 형태의 MEA 면역조직화학 시장
  • MEA 지역의 2021~2028년 다양한 세그먼트별 시장 수익 예측을 얻습니다.
  •  MEA 면역조직화학 시장 세분화

     MEA 면역조직화학 시장 - 제품별

    • 장비
      • 슬라이드 염색 시스템
      • 조직 마이크로어레이 시스템
      • 조직 처리 시스템
      • 슬라이드 스캐너
      • 기타 장비
    • 항체
      • 1차 항체
      • 2차 항체
    • 시약
      • 조직학적 염색
      • 차단 및 고정 시약
      • 색소 기질
      • 고정 시약
      • 안정제
      • 유기 용매
      • 단백질 분해 효소
      • 희석제
    • 키트

    MEA 면역조직화학 시장 - 응용프로그램별

    • 진단
      • 전염병
      • 자가면역질환
      • 당뇨병
      • 신장질환
      • 기타
    • 약물 검사

    MEA 면역조직화학 시장 - 최종 사용자별

    • 병원 및 진단 실험실
    • 연구 기관 li>
    • 기타

    MEA 면역조직화학 시장 - 국가별

    • UAE
    • 사우디아라비아
    • 남아프리카공화국
    • 나머지 MEA     

    MEA 면역조직화학 시장 - 회사 프로필

    • Abcam plc
    • Agilent Technologies, Inc.
    • Bio SB
    • BIO-RAD LABORATORIES INC.
    • Danaher
    • F. HOFFMANN-LA ROCHE LTD.
    • MERCK KGaA
    • PerkinElmer Inc.
    • THERMO FISHER SCIENTIFIC INC.   

    TABLE OF CONTENTS

    1.             Introduction

    1.1       Scope of the Study

    1.2       The Insight Partners Research Report Guidance

    1.3       Market Segmentation

    1.3.1        MEA Immunohistochemistry Market – By Product

    1.3.2        MEA Immunohistochemistry Market – By Application

    1.3.3        MEA Immunohistochemistry Market – By End User

    1.3.4        MEA Immunohistochemistry Market – By Country

    2.             Key Takeaways

    3.             Research Methodology

    3.1       Coverage

    3.2       Secondary Research

    3.3       Primary Research

    4.             MEA Immunohistochemistry Market – Market Landscape

    4.1       Overview

    4.2       MEA PEST Analysis

    4.3       Experts Opinion

    5.             MEA Immunohistochemistry Market – Key Market Dynamics

    5.1       Market Drivers

    5.1.1        Surging Incidences of Chronic and Infectious Diseases

    5.1.2        Escalating R&D Investments by Biotechnology & Biopharmaceutical Companies

    5.2       Key Market Restraints

    5.2.1        Issues Related to Immunohistochemistry

    5.3       Key Market Opportunities

    5.3.1        Growing Opportunities in Emerging Countries

    5.4       Future Trends

    5.4.1        Rising Acceptance of Automation in Immunohistochemistry

    5.5       Impact Analysis

    6.             Immunohistochemistry Market – MEA Analysis

    6.1       MEA Immunohistochemistry Market Revenue Forecast and Analysis

    7.             MEA Immunohistochemistry Market Analysis– By Product

    7.1       Overview

    7.2       MEA Immunohistochemistry Market, By Product 2021 & 2028 (%)

    7.3       Antibodies

    7.3.1        Overview

    7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.3.3        Primary Antibodies

    7.3.3.1      Overview

    7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.3.4        Secondary Antibodies

    7.3.4.1      Overview

    7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4       Equipment Market

    7.4.1        Overview

    7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.3        Slide Staining Systems

    7.4.3.1      Overview

    7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.4        Tissue Microarrays

    7.4.4.1      Overview

    7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.5        Tissue Processing Systems

    7.4.5.1      Overview

    7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.6        Slide Scanners

    7.4.6.1      Overview

    7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.7        Other Equipments

    7.4.7.1      Overview

    7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5       Reagents Market

    7.5.1        Overview

    7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.3        Histological Stains

    7.5.3.1      Overview

    7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.4        Blocking Sera & Reagents Market

    7.5.4.1      Overview

    7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.5        Chromogenic Substrates Market

    7.5.5.1      Overview

    7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.6        Stabilizers

    7.5.6.1      Overview

    7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.7        Proteolytic Enzymes

    7.5.7.1      Overview

    7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.8        Organic Solvents

    7.5.8.1      Overview

    7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.9        Fixation Reagents

    7.5.9.1      Overview

    7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.10     Diluents

    7.5.10.1    Overview

    7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.6       Kits Market

    7.6.1        Overview

    7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    8.             MEA Immunohistochemistry Market Analysis – By Application

    8.1       Overview

    8.2       MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    8.3       Diagnostics

    8.3.1        Overview

    8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.3        Cancer

    8.3.3.1      Overview

    8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.4        Infectious Diseases

    8.3.4.1      Overview

    8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.5        Autoimmune Diseases

    8.3.5.1      Overview

    8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.6        Diabetes Mellitus

    8.3.6.1      Overview

    8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.7        Nephrological Diseases

    8.3.7.1      Overview

    8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.8        Others

    8.3.8.1      Overview

    8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

    8.4       Drug Testing

    8.4.1        Overview

    8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

    9.             MEA Immunohistochemistry Market Analysis– By End User

    9.1       Overview

    9.2       MEA Immunohistochemistry Market, By End User 2021 & 2028 (%)

    9.3       Hospital & Diagnostic Laboratories

    9.3.1        Overview

    9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    9.4       Research Institutes

    9.4.1        Overview

    9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    9.5       Others

    9.5.1        Overview

    9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.          MEA Immunohistochemistry Market – Country Analysis

    10.1    MEA Immunohistochemistry Market Revenue and Forecasts To 2028

    10.1.1     MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.1.1.1    UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.1.1    UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.1.2    UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.1.2.1        UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.1.2.2        UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.1.2.3        UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.1.3    UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.1.3.1        UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.1.4    UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.1.2    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.2.1    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.2.2    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.2.2.1        Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.2.2.2        Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.2.2.3        Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.2.3    Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.2.3.1        Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.2.4    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.1.3    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.3.1    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.3.2    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.3.2.1        South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.3.2.2        South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.3.2.3        South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.3.3    South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.3.3.1        South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.3.4    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.1.4    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.4.1    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.4.2    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.4.2.1        Rest of MEA Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.4.2.2        Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.4.2.3        Rest of MEA Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.4.3    Rest of MEA Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.4.3.1        Rest of MEA Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.4.4    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    11.          Impact Of COVID-19 Pandemic on MEA Immunohistochemistry Market

    11.1    MEA: Impact Assessment of COVID-19 Pandemic

    12.          Industry Landscape

    12.1    Overview

    12.2    Organic Developments

    12.2.1     Overview

    12.3    Inorganic developments

    12.3.1     Overview

    13.          Company Profiles

    13.1    F. HOFFMANN-LA ROCHE LTD.

    13.1.1     Key Facts

    13.1.2     Business Description

    13.1.3     Products and Services

    13.1.4     Financial Overview

    13.1.5     SWOT Analysis

    13.1.6     Key Developments

    13.2    MERCK KGaA

    13.2.1     Key Facts

    13.2.2     Business Description

    13.2.3     Products and Services

    13.2.4     Financial Overview

    13.2.5     SWOT Analysis

    13.2.6     Key Developments

    13.3    PerkinElmer Inc.

    13.3.1     Key Facts

    13.3.2     Business Description

    13.3.3     Products and Services

    13.3.4     Financial Overview

    13.3.5     SWOT Analysis

    13.3.6     Key Developments

    13.4    THERMO FISHER SCIENTIFIC INC.

    13.4.1     Key Facts

    13.4.2     Business Description

    13.4.3     Products and Services

    13.4.4     Financial Overview

    13.4.5     SWOT Analysis

    13.4.6     Key Developments

    13.5    Abcam plc

    13.5.1     Key Facts

    13.5.2     Business Description

    13.5.3     Products and Services

    13.5.4     Financial Overview

    13.5.5     SWOT Analysis

    13.5.6     Key Developments

    13.6    Agilent Technologies, Inc.

    13.6.1     Key Facts

    13.6.2     Business Description

    13.6.3     Products and Services

    13.6.4     Financial Overview

    13.6.5     SWOT Analysis

    13.6.6     Key Developments

    13.7    BIO-RAD LABORATORIES INC.

    13.7.1     Key Facts

    13.7.2     Business Description

    13.7.3     Products and Services

    13.7.4     Financial Overview

    13.7.5     SWOT Analysis

    13.7.6     Key Developments

    13.8    Danaher

    13.8.1     Key Facts

    13.8.2     Business Description

    13.8.3     Products and Services

    13.8.4     Financial Overview

    13.8.5     SWOT Analysis

    13.8.6     Key Developments

    13.9    Bio SB

    13.9.1     Key Facts

    13.9.2     Business Description

    13.9.3     Products and Services

    13.9.4     Financial Overview

    13.9.5     SWOT Analysis

    13.9.6     Key Developments

    14.          Appendix

    14.1    About The Insight Partners

    14.2    Glossary of Terms

    LIST OF TABLES

    Table 1.             MEA Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

    Table 2.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 3.             UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 4.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 5.             UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 6.             UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 7.             UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 8.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 9.             Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 10.          Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 11.          Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 12.          Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 13.          Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 14.          Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 15.          Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 16.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 17.          South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 18.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 19.          South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 20.          South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 21.          South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 22.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 23.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 24.          Rest of MEA Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 25.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 26.          Rest of MEA Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 27.          Rest of MEA Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 28.          Rest of MEA Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 29.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 30.          Organic Developments Done By Companies

    Table 31.          Inorganic developments done by Companies

    Table 32.          Glossary of Terms

    LIST OF FIGURES

    Figure 1.           MEA Immunohistochemistry Market Segmentation

    Figure 2.           MEA Immunohistochemistry Market Segmentation, By Country

    Figure 3.           MEA Immunohistochemistry Market Overview

    Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

    Figure 5.           The UAE to Show Significant Growth During Forecast Period

    Figure 6.           MEA PEST Analysis

    Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to MEA Immunohistochemistry Market

    Figure 8.           MEA Immunohistochemistry Market – Revenue Forecast and Analysis

    Figure 9.           MEA Immunohistochemistry Market, by Product 2021 & 2028 (%)

    Figure 10.        MEA Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 11.        MEA Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 12.        MEA Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 13.        MEA Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 14.        MEA Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 15.        MEA Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 16.        MEA Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 17.        MEA Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 18.        MEA Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 19.        MEA Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 20.        MEA Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 21.        MEA Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 22.        MEA Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 23.        MEA Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 24.        MEA Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 25.        MEA Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 26.        MEA Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 27.        MEA Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 28.        MEA Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 29.        MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    Figure 30.        MEA Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 31.        MEA Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 32.        MEA Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 33.        MEA Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 34.        MEA Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 35.        MEA Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 36.        MEA Others Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 37.        MEA Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 38.        MEA Immunohistochemistry Market, by End User 2021 & 2028 (%)

    Figure 39.        MEA Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 40.        MEA Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 41.        MEA Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 42.        MEA Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 43.        MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 44.        UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 45.        Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 46.        South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 47.        Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 48.        Impact of COVID-19 Pandemic in MEA Country Markets

    1. Abcam plc
    2. Agilent Technologies, Inc.
    3. Bio SB
    4. BIO-RAD LABORATORIES INC.
    5. Danaher
    6. F. HOFFMANN-LA ROCHE LTD.
    7. MERCK KGaA
    8. PerkinElmer Inc.
    9. THERMO FISHER SCIENTIFIC INC.    
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA immunohistochemistry market.      
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the MEA immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000